申请人:ORTHO PHARMACEUTICAL CORPORATION
公开号:EP0138491A2
公开(公告)日:1985-04-24
The synthesis of substituted 2(1H)-quinazolinone-1-alkanoic acids and their esters is described. The novel quinazolinones are renal vasodilators and as such reduce vascular resistance to renal blood flow. The quinazolinones are useful as cardiovascular agents.
介绍了取代的 2(1H)-
喹唑啉酮-1-烷酸及其
酯类的合成。 新型
喹唑啉酮类是肾血管扩张剂,因此可降低肾血流的血管阻力。
喹唑啉酮类可用作心血管药物。